Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells

SIMPLE SUMMARY: Existing chemotherapy treatments for breast cancer patients are high on toxicity. There are very limited options available for triple-positive breast cancer (TPBC) patients, and there have not been any major breakthrough for targeted therapy for triple-negative breast cancer (TNBC) p...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajput, Kajal, Ansari, Mohammad Nafees, Jha, Somesh K., Pani, Trishna, Medatwal, Nihal, Chattopadhyay, Somdeb, Bajaj, Avinash, Dasgupta, Ujjaini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497187/
https://www.ncbi.nlm.nih.gov/pubmed/36139656
http://dx.doi.org/10.3390/cancers14184496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497187/
https://www.ncbi.nlm.nih.gov/pubmed/36139656
http://dx.doi.org/10.3390/cancers14184496

Ejemplares similares